Clinical trial Recruiting at 2 sites Interventional Ages 18 to 75

Understanding tissue damage and healing in celiac disease

Official title: Tissue Destruction and Healing in Celiac Disease

Run by University of Chicago · NCT05680012 · Data updated 2026-11-12

This study is trying to understand how gluten and other factors affect tissue damage and healing in people with celiac disease, comparing those on a gluten-free diet to those who still eat gluten.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment220 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations3 sites (Pasadena, California and 2 other locations)
StatusRecruiting
StartedJuly 14, 2023
Main results expectedMay 1, 2027
Study endsJuly 1, 2027
Registry record updatedJuly 28, 2026
Trial IDNCT05680012 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 75 with a confirmed diagnosis of celiac disease who have been on a gluten-free diet for at least 12 months or those showing typical symptoms without dietary restrictions.

Probably not a fit

Patients with severe complications of celiac disease or other chronic gastrointestinal diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study aims to investigate the biological mechanisms behind celiac disease, focusing on how factors like genetics, microbiota, and gluten affect tissue damage and healing. Participants will be divided into groups based on their gluten consumption: those on a gluten-free diet and those experiencing symptoms without dietary restrictions. The study will collect data on clinical symptoms and tissue health to improve patient care and understanding of the disease. By examining these interactions, researchers hope to fill gaps in knowledge regarding the variability in disease presentation and recovery among individuals.

Why it matters

Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients with celiac disease.

How similar studies have gone: Other studies have explored aspects of celiac disease, but this specific approach to understanding tissue destruction and healing is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Gluten challenge group:

1. Age 18 to 75 years old
2. Diagnosis of Celiac disease for at least 12 months by intestinal biopsy
3. Follow a strict gluten-free diet for at least the 12 consecutive months

Gluten de-challenge group:

1. Age 18 to 75 years old
2. Showing typical celiac disease symptoms
3. Not on a gluten-free diet

Control group:

1. Age 18 to 75 years old
2. Females who are not pregnant

Exclusion Criteria:

Gluten challenge group:

1. Diagnosis of any severe complication of celiac disease
2. Diagnosis of other chronic, active GI disease
3. Selective IgA deficiency
4. Severe reaction to gluten exposure
5. Any clinically significant diseases
6. History of significant substance or alcohol abuse
7. Pregnant or lactating
8. Diagnosis of blood clotting disorders

Gluten de-challenge group:

1. History of chronic inflammatory gastrointestinal disease
2. Gastrointestinal illness within the 4-week period prior to screening
3. History of lymphoproliferative disease
4. Uncontrolled blood clotting disorders
5. Any clinically significant diseases
6. History of significant substance or alcohol abuse

Control group:

1. Taking antibiotics, proton pump inhibitors, aspirin, or non-steroidal anti-inflammatory drugs
2. Known intestinal inflammation
3. Prior gastrointestinal surgery
4. Taking of antiplatelet agents or anticoagulants
5. Family history of celiac disease

Where it's running

  • The University of Chicago
    Chicago, Illinois, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • California Institute of Technology
    Pasadena, California, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.